REFRESH OPTIVE- carboxymethylcellulose sodium and glycerin solution/ drops 
Allergan, Inc.

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

Drug Facts

Active ingredients

Carboxymethylcellulose sodium 0.5%

Glycerin 0.9%

Purpose

Eye lubricant

Eye lubricant

Uses

Warnings

Stop use and ask a doctor if you experience eye pain, changes in vision, continued redness, or irritation of the eye, or if the condition worsens or persists for more than 72 hours.

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Directions

Instill 1 or 2 drops in the affected eye(s) as needed.

Other information

Inactive ingredients

Boric acid; calcium chloride dihydrate; erythritol; levocarnitine; magnesium chloride hexahydrate; potassium chloride; purified water; PURITE® (stabilized oxychloro complex); sodium borate decahydrate; and sodium citrate dihydrate.

Questions or comments?

Telephone
1.800.433.8871
M-F 6 AM - 4:30 PM
Pacific Time
refreshbrand.com

Refresh
Optive
®
Lubricant Eye Drops

Advanced dual action
formula that lubricates
and hydrates dry eyes

MOISTURIZING DRY EYE SOLUTION

0.5 fl oz (15 mL) Sterile

Carton
REFRESH OPTIVE 
carboxymethylcellulose sodium and glycerin solution/ drops
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:0023-3240
Route of AdministrationOPHTHALMICDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
carboxymethylcellulose sodium (carboxymethylcellulose) carboxymethylcellulose sodium5 mg  in 1 mL
glycerin (glycerin) glycerin9 mg  in 1 mL
Inactive Ingredients
Ingredient NameStrength
boric acid 
calcium chloride 
erythritol 
levocarnitine 
magnesium chloride 
potassium chloride 
water 
sodium chlorite 
sodium chlorate 
chlorine dioxide 
sodium borate 
trisodium citrate dihydrate 
Packaging
#Item CodePackage Description
1NDC:0023-3240-031 in 1 CARTON
13 mL in 1 BOTTLE, DROPPER
2NDC:0023-3240-102 in 1 CARTON
25 mL in 1 BOTTLE, DROPPER
3NDC:0023-3240-151 in 1 CARTON
315 mL in 1 BOTTLE, DROPPER
4NDC:0023-3240-012 in 1 CARTON
415 mL in 1 BOTTLE, DROPPER
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalpart34909/06/2006
Labeler - Allergan, Inc. (144796497)
Establishment
NameAddressID/FEIBusiness Operations
Allergan, Inc.362898611MANUFACTURE(0023-3240)

Revised: 06/2012
Document Id: 6fd4509b-cd07-4fdb-a931-e019d810784f
Set id: 7f8d88af-fd3b-4138-af61-f24c59ccebd7
Version: 3
Effective Time: 20120627
 
Allergan, Inc.